Catalog Number:
CPTC-HRAS-1
Target Antigen:
HRas Proto-Oncogene, GTPase
Isotype:
IgG1
Species:
Mouse Monoclonal Antibody
Last Updated:
07/01/2025
Antigen Recognition(s):
Recombinant Full-length, Endogenous
Result: High Binding
Affinity and binding kinetics of CPTC-HRAS-1 antibody and HRAS recombinant protein using biolayer interferometry. CPTC-HRAS-1 antibody was covalently immobilized on amine-reactive second-generation sensors. HRAS recombinant protein, 1024 nM, 256 nM, 64 nM, 16 nM, 4.0 nM and 1 nM, was used as analyte.
Result: No Binding
Affinity and binding kinetics of CPTC-HRAS-1 and HRAS recombinant protein using surface plasmon resonance. CPTC-HRAS-1 was amine coupled onto a Series S CM5 biosensor chip. HRAS recombinant protein, 1024 nM, 256 nM, 64 nM, 16 nM, 4 nM and 1.0 nM, was used as analyte. Kinetic constant Ka is approaching the limits that can be measured by the instrument.
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
Result: Negative
Immuno-precipitation screening of antibody CPTC-HRAS-1 in cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS and in MCF7 cell lysate. IP eluates were tested in WB using CPTC-HRAS-1 as detection antibody (IP-WB), The antibody showed specificity for HRAS. Expected MW is ~21KDa. The target was also pulled down in the MCF7 lysate.
Result: Positive
Immunofluorescence staining of Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein using CPTC-HRAS-1 antibody (green). HRAS protein expression shows localization to the nucleoplasm and cytosol.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: High Binding
Indirect ELISA using CPTC-HRAS-1 as primary antibody against HRAS recombinant protein.
Result: Positive
Protein Array in which CPTC-HRAS-1 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression level (red).
Result: Positive
Western Blot using CPTC-HRAS-1 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Automated Western Blot using CPTC-HRAS-1 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Single cell western blot for HRAS protein using CPTC-HRAS-1 as a primary antibody against whole cell lysates prepared from Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein. Relative expression of total HRAS (A). Percentage of cells that express HRAS (B). Average expression of HRAS protein per cell (C). Molecular weight detected is higher than expected. All data is normalized to β-tubulin expression.
Result: Presumed Positive (with additional bands)
Western Blot using CPTC-HRAS-1 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Presumed positive for MCF7. Expected MW is ~21KDa.
Result: Positive
Automated Western Blot using CPTC-HRAS-1 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Positive for MCF7. Expected MW is ~21KDa.
Catalog Number:
CPTC-HRAS-2
Target Antigen:
HRas Proto-Oncogene, GTPase
Isotype:
IgG2a
Species:
Mouse Monoclonal Antibody
Last Updated:
07/01/2025
Antigen Recognition(s):
Recombinant Full-length, Endogenous
Result: High Binding
Affinity and binding kinetics of CPTC-HRAS-2 antibody and HRAS recombinant protein using biolayer interferometry. CPTC-HRAS-2 antibody was covalently immobilized on amine-reactive second-generation sensors. HRAS recombinant protein, 64 nM, 16 nM, 4.0 nM, 1 nM and 0.25 nM, was used as analyte.
Result: High Binding
Affinity and binding kinetics of CPTC-HRAS-2 and HRAS recombinant protein using surface plasmon resonance. CPTC-HRAS-2 was amine coupled onto a Series S CM5 biosensor chip. HRAS recombinant protein, 1024 nM, 256 nM, 64 nM, 16 nM, 4 nM and 0.25 nM, was used as analyte.
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Positive
Tissue Micro-Array (TMA) core of breast cancer showing cytoplasmic and membranous staining using Antibody CPTC-HRAS-2. Titer: 1:500
Result: Positive
Immuno-precipitation screening of antibody CPTC-HRAS-2 in cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS and in MCF7 cell lysate. IP eluates were tested in WB using CPTC-HRAS-1 as detection antibody (IP-WB), The antibody showed specificity for HRAS. Expected MW is ~21KDa. The target was also pulled down in the MCF7 lysate.
Result: Negative
Immunofluorescence staining of Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein using CPTC-HRAS-2 antibody. HRAS protein expression was not detected.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: High Binding
Indirect ELISA using CPTC-HRAS-2 as primary antibody against HRAS recombinant protein.
Result: Positive
Protein Array in which CPTC-HRAS-2 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression level (red).
Result: Positive
Western Blot using CPTC-HRAS-2 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Automated Western Blot using CPTC-HRAS-2 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Single cell western blot for HRAS protein using CPTC-HRAS-2 as a primary antibody against whole cell lysates prepared from Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein. Relative expression of total HRAS (A). Percentage of cells that express HRAS (B). Average expression of HRAS protein per cell (C). Molecular weight detected is higher than expected. All data is normalized to β-tubulin expression.
Result: Presumed Positive (with additional bands)
Western Blot using CPTC-HRAS-2 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Presumed positive for MCF7. Expected MW is ~21KDa.
Result: Presumed Positive (with additional bands)
Autometed Western Blot using CPTC-HRAS-2 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Presumed positive for MCF7. Expected MW is ~21KDa.
Catalog Number:
CPTC-HRAS-3
Target Antigen:
HRas Proto-Oncogene, GTPase
Isotype:
IgG1
Species:
Mouse Monoclonal Antibody
Last Updated:
07/01/2025
Antigen Recognition(s):
Recombinant Full-length, Endogenous
Result: High Binding
Affinity and binding kinetics of CPTC-HRAS-3 antibody and HRAS recombinant protein using biolayer interferometry. CPTC-HRAS-3 antibody was covalently immobilized on amine-reactive second-generation sensors. HRAS recombinant protein, 256 nM, 64 nM, 16 nM, 4.0 nM, 1 nM and 0.25 nM, was used as analyte.
Result: No Binding
Affinity and binding kinetics of CPTC-HRAS-3 and HRAS recombinant protein using surface plasmon resonance. CPTC-HRAS-3 was amine coupled onto a Series S CM5 biosensor chip. KRAS4A recombinant protein, 1024 nM, 256 nM, 64 nM, 16 nM, 4 nM and 1.0 nM, was used as analyte. Kinetic constant Ka is approaching the limits that can be measured by the instrument.
Result: Positive
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
This antibody is not suitable for use in an Immunohistochemistry format as described in SOP M-106.
Result: Negative
Immuno-precipitation screening of antibody CPTC-HRAS-3 in cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS and in MCF7 cell lysate. IP eluates were tested in WB using CPTC-HRAS-1 as detection antibody (IP-WB), The antibody showed specificity for HRAS. Expected MW is ~21KDa. The target was also pulled down in the MCF7 lysate.
Result: Negative
Immunofluorescence staining of Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein using CPTC-HRAS-3 antibody. HRAS protein expression was not detected.
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: High Binding
Indirect ELISA using CPTC-HRAS-3 as primary antibody against HRAS recombinant protein.
Result: Positive
Protein Array in which CPTC-HRAS-3 is screened against the NCI60 cell line panel for expression. Data is normalized to a mean signal of 1.0 and standard deviation of 0.5. Color conveys over-expression level (green), basal level (blue), under-expression level (red).
Result: Positive
Western Blot using CPTC-HRAS-3 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Automated Western Blot using CPTC-HRAS-3 as primary antibody against cell lysates of Mouse Embryonic Fibroblasts (MEFs) stably transfected with KRas4a, KRas4b, HRAS and NRAS. The antibody showed specificity for HRAS. Expected MW is ~21KDa.
Result: Positive
Single cell western blot for HRAS protein using CPTC-HRAS-3 as a primary antibody against whole cell lysates prepared from Mouse Embryonic Fibroblasts (MEFs) stably transfected with HRAS-WT protein. Relative expression of total HRAS (A). Percentage of cells that express HRAS (B). Average expression of HRAS protein per cell (C). Molecular weight detected is higher than expected. All data is normalized to β-tubulin expression.
Result: Presumed Positive (with additional bands)
Western Blot using CPTC-HRAS-3 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Presumed positve for MCF7. Expected MW is ~21KDa.
Result: Positive
Autometed Western Blot using CPTC-HRAS-3 as primary antibody against cell lysates of HeLa, Jurkat, A549, MCF7 and H226. Positive for MCF7. Expected MW is ~21KDa.
Catalog Number:
CPTC-HRAS-4
Target Antigen:
HRas Proto-Oncogene, GTPase
Isotype:
IgG
Species:
Rabbit Monoclonal Antibody
Last Updated:
05/15/2025
Antigen Recognition(s):
Recombinant Full-length
Result: Positive
Imaging mass cytometry on ovarian cancer tissue core using CPTC-HRAS-4 metal-labeled antibody. Data shows overlay of target protein signal (red) and DNA (blue). Dilution: 1:100 of 0.5mg/mL stock. Signal was also obtained in other normal tissues (testis, colon, endometrium, appendix, bone marrow, breast, kidney, and lung) and cancer tissues (breast, colon, ovarian, lung, and prostate).
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
Result: Negative
Results provided by the Human Protein Atlas (www.proteinatlas.org).
NCI Identification Number:
00490
Antigen Name:
HRas Proto-Oncogene, GTPase
CPTC Name:
CPTC-HRAS
Aliases:
HRas Proto-Oncogene, GTPase; V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog; Harvey Rat Sarcoma Viral Oncogene Homolog; Transforming Protein P21; GTPase HRas; P21ras; HRAS1; Ras Family Small GTP Binding Protein H-Ras; Harvey Rat Sarcoma Viral Oncoprotein; Transformation Gene: Oncogene HAMSV; GTP- And GDP-Binding Peptide B; Ha-Ras1 Proto-Oncoprotein; C-Has/Bas P21 Protein; P19 H-RasIDX Protein; EC 3.6.5.2; C-BAS/HAS; C-HA-RAS1; H-RASIDX; C-H-RAS; H-Ras-1; C-H-Ras; Ha-Ras; HAMSV; RASH1; CTLO; HRAS
Function:
This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.HRAS (HRas Proto-Oncogene, GTPase) is a Protein Coding gene. Diseases associated with HRAS include Costello Syndrome and Nevus, Epidermal. Among its related pathways are Sertoli-Sertoli Cell Junction Dynamics and ERK Signaling. Gene Ontology (GO) annotations related to this gene include GTP binding and protein C-terminus binding. An important paralog of this gene is KRAS.Involved in the activation of Ras protein signal transduction (PubMed:22821884). Ras proteins bind GDP/GTP and possess intrinsic GTPase activity
Chromosomal Localization:
11p15.5
Expression System:
Baculovirus
Accession Number:
NP_005334.1
UniProt Accession Number:
P01112
DNA Source:
N/A
Immunogen:
Recombinant Full Length Protein
Vector Name:
xx
Extinction Coefficient:
Buffers:
Expressed Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGET
CLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQI
KRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQ
GVEDAFYTLVREIRQHKLRKLNPPDESGPGCMSCKCVLS
Native Sequence:
Calculated Isoelectric Point:
5.16
Molecular Weight:
21355
Last Updated:
11/17/2021
No SOPs available.
Get it for free at Adobe.com